Literature DB >> 1611621

Induction of antitumor activities in spleen cells from mice and rats activated with lipopolysaccharide immobilized on beads.

H Abe1, T Tani, J Shibata, M Kodama.   

Abstract

Lipopolysaccharides (LPS) were coupled to polystyrene beads in order to apply the LPS without toxicity. The antitumor activity of the LPS-immobilizing beads was studied in experiments in vitro and in vivo. In vitro studies showed that spleen cells from C3H/HeN mice stimulated by beads immobilizing LPS from Escherichia coli produced cytolytic activity as strong as that of lymphokine-activated killer (LAK) cells. Spleen cells from Sprague-Dawley rats stimulated by beads immobilizing LPS from Salmonella minnesota produced cytolytic activity stronger than that of LAK cells. However, spleen cells stimulated by beads immobilizing each component of the LPS separately could not induce cytolysis. Contact stimulation, even for a brief period, sufficed for cytolytic activity, and was enhanced by culture for 48-72 h. Through in vivo studies, the suppression of tumor growth and a prolongation of the survival time were observed in tumor-bearing mice injected with spleen cells activated by beads immobilizing LPS from E. coli, and in mice injected with LAK cells. The effect of the activated spleen cells was stronger than that of the LAK cells. In rats bearing metastatic tumors, spleen cells activated by beads immobilizing LPS from S. minnesota suppressed lung metastases more strongly than did LAK cells. These findings indicate that LPS immobilized by beads induced killer cells more strongly than interleukin-2. Ex vivo immunomodulation with LPS-immobilizing beads can be applied usefully as an anticancer treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611621     DOI: 10.1007/bf01741053

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  16 in total

1.  Coupling of Escherichia coli lipopolysaccharide to epoxy-activated Sepharose 6B.

Authors:  J Fox; K Hechemy
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

2.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

3.  Plasmapheresis in patients with disseminated cancer: clinical results and correlation with changes in serum protein. The concept of "nonspecific blocking factors".

Authors:  L Israel; R Edelstein; P Mannoni; E Radot; E M Greenspan
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

4.  A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications.

Authors:  T Obayashi; H Tamura; S Tanaka; M Ohki; S Takahashi; M Arai; M Masuda; T Kawai
Journal:  Clin Chim Acta       Date:  1985-06-30       Impact factor: 3.786

5.  Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A.

Authors:  D S Terman; J B Young; W T Shearer; C Ayus; D Lehane; C Mattioli; R Espada; J F Howell; T Yamamoto; H I Zaleski; L Miller; P Frommer; L Feldman; J F Henry; R Tillquist; G Cook; Y Daskal
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

6.  Efficacy and biocompatibility of a novel anti-cancer fiber in hemoperfusion on cancer-bearing rabbits.

Authors:  T Tani; M Kodama; T Oka; K Hanasawa; K Teramoto; S Nishiumi
Journal:  Trans Am Soc Artif Intern Organs       Date:  1984

7.  Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

Authors:  I Hellström; H O Sjögren; G Warner; K E Hellström
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

8.  Trial of anticancer immunotherapy with immobilized pokeweed mitogen: immunotherapy by extracorporeal circulation.

Authors:  K Numa; T Tani; M Kodama
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Extracorporeal interferon therapy in malignant melanoma. Significant economies of interferon in an extracorporeal chamber.

Authors:  E Langvad; H Hydén; J K Petersen; R Jordal; G Olsen
Journal:  Arzneimittelforschung       Date:  1980

10.  Isolation of a nontoxic lipid A fraction containing tumor regression activity.

Authors:  K Takayama; E Ribi; J L Cantrell
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.